Association Innovative Medicines

Association Innovative Medicines

Association Innovative Medicines

The Association Innovative Medicines is the industry association for the Dutch branches of innovative pharmaceutical companies. The association has 44 members and promotes their interests in pharmaceutical research and the pharmaceutical industry. The aim of the Association is to improve access to new medicines for patients, to create an excellent R&D climate and express the value of innovative medicines.

 

Ipsen is a global biopharmaceutical group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. Our strategy is to build a global biopharma company focused on innovation and specialty care which delivers differentiated therapeutics to meet unmet patient needs.


 

As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments. Our strategy is to use science-based innovation to deliver better patient outcomes in growing areas of healthcare. At Novartis, we are reimagining medicine.

 


Our focus is on fitting treatments to patients: providing the right therapy for the right group of people at the right time. With our in-house combination of Pharmaceuticals and Diagnostics, we are uniquely positioned to deliver personalised healthcare.

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners